Cue Biopharma Inc (CUE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cue Biopharma Inc   (NASDAQ: CUE)


Cue Biopharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cue Biopharma Inc's ROI in the second quarter of 2026?
Cue Biopharma Inc recorded a cumulative net loss of $-164 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -843.6%.

Within the Healthcare sector 543 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3796 to 3948.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -11.76 % -5.1 % -31.52 % -47.78 % -45.62 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 9 23 29 16 21
Return On Investment (TTM) -843.6 % -86.98 % -132.13 % -204.67 % -176.43 %
CUE's Overall Ranking # 3948 # 3796 # 3037 # 4039 # 3466
Seq. Investment Change TTM -13.33 % 11.48 % 9.35 % -16.49 % -6.78 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -164 -20 -27 -38 -39

CUE Company Profile >> Back to CUE Roi Comparisons >> See Annual CUE Return On Investment



Return On Investment CUE's Ranking
Within: No.
Industry # 253
Sector # 544
Overall # 3948

Return On Investment Statistics
High Average Low
-10.32 %
-116.38 %
-843.6 %
(Mar 31 2018)   (Jun 30 2026)







Financial Statements
Cue Biopharma Inc's II. Quarter Investments $ 9 Millions CUE's Balance sheet
Cue Biopharma Inc's II. Quarter Income $ -153 Millions Quarterly CUE's Income Statement
CUE's Income by Division See CUE's Income by Division


CUE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 29 22 45 80 71
Y / Y Investment Growth 31.54 % -51.75 % -43.25 % 12.92 % -15.15 %
Net Income in Millions -27 -41 -51 -53 -44
Y / Y Net Income Growth - - - - -
Annual Return On Investment -92.63 % -186.3 % -112.12 % -66.48 % -62.54 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CUE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CUE's Competitors
Subscribers only: Roi for Cue Biopharma Inc's Suppliers
Subscribers only: Return On Investment for CUE's Customers

Other Ratios
CUE's Roa CUE's Inventory Turnover Ratio CUE's Growth Rates CUE's Dividend Statistics
CUE's Profitability Ratios CUE's Asset Turnover Ratio CUE's Dividend Growth
CUE's Roe CUE's Valuation Ratios CUE's Financial Strength Ratios CUE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T17:18:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.